Bayer reported 32.45B in Current Assets for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Akzo Nobel AKZA:NA 5.49B 318M
Amarin AMRN:US $ 995.98M 65.47M
Arkema AKE:FP € 5195M 844M
AstraZeneca AZN:LN 27.27B 8.54B
BASF BAS:GR 33.12B 1.5B
Bayer BAYN:GR 32.45B 3.35B
Corteva Inc CTVA:US $ 14.28B 751M
Covestro 1COV:GR 6.53B 518M
DSM DSM:NA € 5425M 880M
Fresenius FRE:GR € 16901M 208M
Fresenius Medical Care FME:GR € 7815M 26M
Genmab GEN:DC 20.3B 367M
Givaudan GIVN:VX 3.61B 307M
GlaxoSmithKline GSK:LN 17.57B 958M
GRIFOLS GRF:SM € 3239.5M 153.93M
H. Lundbeck A/S LUN:DC 8.15B 38M
Hikma Pharmaceutical HIK:LN 1.96B 33M
Johnson Matthey JMAT:LN 4.87B 505M
Linde LIN:GR 10.45B 686M
Lonza Group LONN:SW 5.03B 229M
Merck MRK:GR € 10182M 435M
Novartis NOVN:VX 23.81B 1.61B
Nutrien Ltd NTR:CN C$ 13.88B 1.4B
Ppg Industries PPG:US $ 7300M 146M
SAP SAP:GR 16.5B 3.58B
Solvay SOLB:BB € 5317M 105M
Umicore UMI:BB 6.38B 934.9M